Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)

This study has been completed.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: November 19, 2008
Last updated: April 1, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2003
  Primary Completion Date: July 2003 (Final data collection date for primary outcome measure)